Assignee profile:

Affiris AG

City:

Vienna

Country:

Austria

Published Applications:

42

Last publication date:

2022-03-10

Patent Grants:

28

Last grant date:

2024-08-20

Top Inventors for applications by Affiris AG

These are the the leading inventors for applications assigned to Affiris AG:

Recent patent applications by Affiris AG

Affiris AG based in Vienna, AT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-03-10 βœ… Patent 12,065,509 granted on 2024-08-20
US20220073650A1
Chemistry; metallurgy

Substances and methods for the use in prevention and/or treatment in huntingon's disease

#2 | 2021-02-11
US20210040236A1
Chemistry; metallurgy

SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGTON'S DISEASE

#3 | 2020-10-29 βœ… Patent 11,147,873 granted on 2021-10-19
US20200338192A1
Human necessities

Treatment of Alzheimer's Disease (AD) with an aluminum salt

#4 | 2020-08-13 βœ… Patent 11,534,484 granted on 2022-12-27
US20200254076A1
Human necessities

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy

#5 | 2020-01-16
US20200016249A1
Human necessities

IL-23-P19 VACCINES

#6 | 2019-05-02
US20190127438A1
Chemistry; metallurgy

ALPHA CHAIN OF THE HIGH-AFFINITY IGE RECEPTOR (FCERIA)

#7 | 2019-03-28 βœ… Patent 12,290,553 granted on 2025-05-06
US20190091306A1
Human necessities

Method for vaccination against a self-antigen in a human patient

#8 | 2018-11-15
US20180327513A1
Chemistry; metallurgy

SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGTON'S DISEASE

#9 | 2018-10-11 βœ… Patent 10,933,123 granted on 2021-03-02
US20180289781A1
Human necessities

Peptide vaccines usable for hypercholesterolemia related diseases

#10 | 2018-07-05
US20180186896A1
Chemistry; metallurgy

VACCINES FOR THE TREATMENT AND PREVENTION OF IGE MEDIATED DISEASES

#11 | 2018-04-26 βœ… Patent 10,576,131 granted on 2020-03-03
US20180110846A1
Human necessities

IL-23-p19 vaccines

#12 | 2017-10-26 βœ… Patent 10,406,197 granted on 2019-09-10
US20170304384A1
Human necessities

Substances and methods for the use in prevention and/or treatment in Huntington's disease

#13 | 2017-06-08 βœ… Patent 10,517,935 granted on 2019-12-31
US20170158744A1
Chemistry; metallurgy

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

#14 | 2017-05-25 βœ… Patent 10,053,518 granted on 2018-08-21
US20170145117A1
Chemistry; metallurgy

Substances and methods for the use in prevention and/or treatment in Huntington's disease

#15 | 2017-05-18
US20170137509A1
Chemistry; metallurgy

VACCINES AND MONOCLONAL ANTIBODIES TARGETING TRUNCATED VARIANTS OF OSTEOPONTIN AND USES THEREOF

#16 | 2017-04-27 βœ… Patent 9,999,659 granted on 2018-06-19
US20170112908A1
Human necessities

Treatments using a peptide and/or vaccine

#17 | 2017-03-09 βœ… Patent 10,004,791 granted on 2018-06-26
US20170065689A1
Human necessities

Peptide vaccines against PCSK9

#18 | 2017-03-02 βœ… Patent 10,646,565 granted on 2020-05-12
US20170056495A1
Human necessities

Treatment of alzheimer'S disease (AD) with an aluminum salt

#19 | 2017-02-23 βœ… Patent 10,478,454 granted on 2019-11-19
US20170049812A1
Human necessities

Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide

#20 | 2017-02-23 βœ… Patent 11,065,273 granted on 2021-07-20
US20170049810A1
Human necessities

Treatment and prevention of alzheimer's disease (AD)

#21 | 2016-04-21 βœ… Patent 9,669,079 granted on 2017-06-06
US20160106822A1
Human necessities

PCSK9 peptide combination vaccine and method of use

#22 | 2016-02-25 βœ… Patent 9,964,547 granted on 2018-05-08
US20160054333A1
Physics

Method for detecting aSyn-specific antibodies in a biological sample

#23 | 2016-01-14
US20160008443A1
Human necessities

METHOD FOR TREATING A beta-AMYLOIDOSIS

#24 | 2015-10-29
US20150306194A1
Human necessities

METHOD FOR TREATING A SYNUCLEIOPATHY

#25 | 2015-10-29 βœ… Patent 9,533,030 granted on 2017-01-03
US20150306191A1
Human necessities

Vaccine capable of inducing formation of antibodies directed to proprotein convertase subtilisin/kexin type 9 (PCSK9) in vivo

#26 | 2015-06-18 βœ… Patent 10,344,062 granted on 2019-07-09
US20150166620A1
Chemistry; metallurgy

Method of inhibiting C5a

#27 | 2015-04-02
US20150093432A1
Human necessities

COMPOSITION

#28 | 2015-04-02
US20150093431A1
Human necessities

COMPOSITIONS

#29 | 2015-03-12 βœ… Patent 9,220,762 granted on 2015-12-29
US20150071951A1
Human necessities

PCSK9 peptide combination vaccine and method of use

#30 | 2014-09-11
US20140255435A1
Human necessities

Vaccine

#31 | 2014-08-28 βœ… Patent 9,625,459 granted on 2017-04-18
US20140242727A1
Physics

Method for diagnosing alzheimer's disease (AD)

#32 | 2014-08-21
US20140234877A1
Physics

METHOD FOR DETECTING A BETA-SPECIFIC ANTIBODIES IN A BIOLOGICAL SAMPLE

#33 | 2014-06-26
US20140179900A1
Chemistry; metallurgy

TREATMENT OF ATHEROSCLEROSIS WITH CHOLESTEROL ESTER TRANSPORT PROTEIN MIMOTOPES

#34 | 2014-05-29 βœ… Patent 9,085,636 granted on 2015-07-21
US20140147456A1
Chemistry; metallurgy

CETP fragments

#35 | 2013-08-22 βœ… Patent 9,457,078 granted on 2016-10-04
US20130216565A1
Human necessities

Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein

#36 | 2012-10-25 βœ… Patent 9,029,327 granted on 2015-05-12
US20120269836A1
Human necessities

Vaccine

#37 | 2012-06-21 βœ… Patent 8,828,942 granted on 2014-09-09
US20120156234A1
Human necessities

Means for treating synucleinopathies

#38 | 2011-11-10 βœ… Patent 8,618,046 granted on 2013-12-31
US20110275556A1
Chemistry; metallurgy

Treatment of atherosclerosis with cholesterol ester transport protein mimotopes

#39 | 2011-07-14 βœ… Patent 8,409,581 granted on 2013-04-02
US20110171243A1
Chemistry; metallurgy

Compounds for treating amyloidoses

#40 | 2011-04-28 βœ… Patent 8,613,931 granted on 2013-12-24
US20110097351A1
Human necessities

Compounds for treating beta-amyloidoses

#41 | 2011-04-21
US20110092436A1
Human necessities

COMPOUNDS FOR TREATING SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE

#42 | 2011-04-21 βœ… Patent 9,724,399 granted on 2017-08-08
US20110092434A1
Human necessities

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

Also check out AFFIRIS AG's (Vienna, Austria) applicant profile with 15 patent applications submitted.

AssigneeID:

35855 ⎘